Your session is about to expire
← Back to Search
Virtual Reality Goggles for Procedural Pain in Children
N/A
Recruiting
Led By Courtney A McNamara, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Must not have
Patient refuses Lidocaine 2.5%/Prilocaine 2.5% cream use they will also be excluded from the study.
Patient (>18) or Parent or guardian (for patient < 18) that does not speak English, Spanish or Arabic will be excluded
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 hour prior to venipuncture and again immediately after venipuncture
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether virtual reality goggles can help reduce pain and anxiety during venipuncture for hospitalized children.
Who is the study for?
This trial is for hospitalized children and young adults aged 5-21 who are scheduled for a venipuncture. It's not suitable for those who don't speak English, Spanish or Arabic, refuse topical anesthetic cream, can't use VR due to physical or developmental reasons, have discomfort with goggles (like recent neurosurgery), photosensitive seizures, or infections like scabies, lice, COVID-19.
What is being tested?
The study tests if virtual reality goggles can reduce pain and anxiety during venipuncture in patients aged 5-21 compared to the standard care which includes a topical anesthetic. Participants will be randomly assigned to either receive standard care alone or with the addition of VR goggles.
What are the potential side effects?
There may be no direct side effects from using virtual reality goggles; however, some individuals might experience discomfort wearing them especially after certain medical procedures like neurosurgery or if they have conditions such as migraines.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am willing to use Lidocaine/Prilocaine cream.
Select...
I (or my guardian) can communicate in English, Spanish, or Arabic.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 1 hour prior to venipuncture and again immediate after venipuncture
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 hour prior to venipuncture and again immediate after venipuncture
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Perceived Pain Scale
Secondary study objectives
Change in Anxiety Scores
Change in Heart Rate
Change in Level of simulator sickness
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VR goggle with venipunctureExperimental Treatment1 Intervention
Virtual reality goggles SamsungGearVR supplied by KindVR will be placed on patients at least 2 min prior to venipuncture. All patients will also receive Lidocaine 2.5%/Prilocaine 2.5% cream at least 60 min prior to venipuncture.
Group II: no VR goggle with venipunctureActive Control1 Intervention
Patients will receive Lidocaine 2.5%/Prilocaine 2.5% cream at least 60 min prior to venipuncture but NO virtual reality goggles.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality Goggles
2023
N/A
~110
Find a Location
Who is running the clinical trial?
Montefiore Medical CenterLead Sponsor
457 Previous Clinical Trials
588,421 Total Patients Enrolled
Courtney A McNamara, MDPrincipal InvestigatorMontefiore Medical Center
Share this study with friends
Copy Link
Messenger